{"name": "Corridor Pharmaceuticals",
 "permalink": "corridor-pharmaceuticals",
 "crunchbase_url": "http://www.crunchbase.com/company/corridor-pharmaceuticals",
 "homepage_url": "",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2007,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "",
 "description": "",
 "created_at": "Fri Jul 09 03:56:11 UTC 2010",
 "updated_at": "Fri Jul 09 03:56:10 UTC 2010",
 "overview": "\u003Cp\u003ECorridor Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapeutic small molecule inhibitors of arginase. Its arginase is an enzyme that competes with endothelial nitric oxide synthase for the use of the common substrate l-arginine. The company\u00e2\u20ac\u2122s arginase also leads to the production of ornithine which increases polyamine, stimulating cell division, and contributing to hyperplasia and fibrosis. Corridor Pharmaceuticals, Inc. was formerly known as Arginetix, Inc. and changed its name to Corridor Pharmaceuticals, Inc. on June 17, 2010. The company was founded in 2007 and is based in Lutherville, Maryland.\u003C/p\u003E",
 "image": null,
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "Co-Founder",
    "person":
     {"first_name": "Gary",
      "last_name": "Lessing",
      "permalink": "gary-lessing",
      "image": null}},
   {"is_past": false,
    "title": "Co-Founder",
    "person":
     {"first_name": "Dan",
      "last_name": "Berkowitz",
      "permalink": "dan-berkowitz",
      "image": null}},
   {"is_past": false,
    "title": "Board Member",
    "person":
     {"first_name": "Brian",
      "last_name": "K. Halak",
      "permalink": "brian-k-halak",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$15M",
 "funding_rounds":
  [{"round_code": "a",
    "source_url": "http://finance.yahoo.com/news/Arginetix-and-Immune-Control-bw-1922954142.html?x=0\u0026.v=1",
    "source_description": "Arginetix and Immune Control Merge to Form Corridor Pharmaceuticals",
    "raised_amount": 15000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 6,
    "funded_day": 16,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Domain Associates",
         "permalink": "domain-associates",
         "image":
          {"available_sizes":
            [[[150,
               72],
              "assets/images/resized/0003/2807/32807v1-max-150x150.png"],
             [[250,
               121],
              "assets/images/resized/0003/2807/32807v1-max-250x250.png"],
             [[264,
               128],
              "assets/images/resized/0003/2807/32807v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Quaker BioVentures",
         "permalink": "quaker-bioventures",
         "image":
          {"available_sizes":
            [[[144,
               96],
              "assets/images/resized/0004/9249/49249v2-max-150x150.jpg"],
             [[144,
               96],
              "assets/images/resized/0004/9249/49249v2-max-250x250.jpg"],
             [[144,
               96],
              "assets/images/resized/0004/9249/49249v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "MedImmune Ventures",
         "permalink": "medimmune-ventures",
         "image":
          {"available_sizes":
            [[[150,
               19],
              "assets/images/resized/0004/9449/49449v2-max-150x150.jpg"],
             [[250,
               31],
              "assets/images/resized/0004/9449/49449v2-max-250x250.jpg"],
             [[450,
               57],
              "assets/images/resized/0004/9449/49449v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "NewSpring Capital",
         "permalink": "newspring-capital",
         "image":
          {"available_sizes":
            [[[150,
               114],
              "assets/images/resized/0002/9272/29272v1-max-150x150.jpg"],
             [[153,
               117],
              "assets/images/resized/0002/9272/29272v1-max-250x250.jpg"],
             [[153,
               117],
              "assets/images/resized/0002/9272/29272v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Maryland Health Care Product Development",
         "permalink": "maryland-health-care-product-development",
         "image": null},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Ben Franklin Technology Partners of Southeastern Pennsylvania",
         "permalink": "ben-franklin-technology-partners-of-southeastern-pennsylvania",
         "image":
          {"available_sizes":
            [[[150,
               60],
              "assets/images/resized/0005/5082/55082v1-max-150x150.jpg"],
             [[178,
               72],
              "assets/images/resized/0005/5082/55082v1-max-250x250.jpg"],
             [[178,
               72],
              "assets/images/resized/0005/5082/55082v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company":
        {"name": "Acidophil",
         "permalink": "acidophil",
         "image":
          {"available_sizes":
            [[[150,
               47],
              "assets/images/resized/0004/9450/49450v1-max-150x150.jpg"],
             [[250,
               79],
              "assets/images/resized/0004/9450/49450v1-max-250x250.jpg"],
             [[253,
               80],
              "assets/images/resized/0004/9450/49450v1-max-450x450.jpg"]],
           "attribution": null}},
       "financial_org": null,
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Red Abbey Venture Partners",
         "permalink": "red-abbey-venture-partners",
         "image":
          {"available_sizes":
            [[[150,
               98],
              "assets/images/resized/0004/6604/46604v1-max-150x150.jpg"],
             [[175,
               115],
              "assets/images/resized/0004/6604/46604v1-max-250x250.jpg"],
             [[175,
               115],
              "assets/images/resized/0004/6604/46604v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "2330 West Joppa Road",
    "address2": "Suite 330",
    "zip_code": "21093",
    "city": "Lutherville",
    "state_code": "MD",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}